CIA
DXCM icon

Concurrent Investment Advisors’s DexCom DXCM Stock Holding History

Concurrent Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
5,432
-1,192
-18% -$79.4K ﹤0.01% 1574
2026
Q1 		$416K Buy
6,624
+664
+11% +$46.2K ﹤0.01% 1305
2025
Q4 		$396K Buy
5,960
+1,897
+47% +$123K ﹤0.01% 1249
2025
Q3 		$273K Sell
4,063
-199
-5% -$15.7K ﹤0.01% 1194
2025
Q2 		$372K Buy
+4,262
New +$334K 0.01% 966
2024
Q3 		– Sell
-1,847
Closed -$209K – 1112
2024
Q2 		$209K Buy
1,847
+204
+12% +$25.8K 0.01% 864
2024
Q1 		$228K Sell
1,643
-307
-16% -$38.6K 0.01% 756
2023
Q4 		$242K Buy
+1,950
New +$199K 0.01% 717

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Concurrent Investment Advisors's DXCM Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its DexCom (DXCM) stake by 18% in Q2 2026, selling an estimated $79.4K and leaving 5,432 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Concurrent Investment Advisors first reported a position in DXCM in Q4 2023 and has held it in 8 quarters since. The position peaked at $416K in Q1 2026. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Concurrent Investment Advisors held 5,432 shares of DexCom worth $366K as of Q2 2026.
  • Concurrent Investment Advisors sold 1,192 DexCom shares in Q2 2026, an estimated $79.4K.
  • DexCom made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1574 holding.
  • Concurrent Investment Advisors first reported a position in DexCom in Q4 2023 and has held it in 8 quarters since.
  • Concurrent Investment Advisors's DexCom position peaked at $416K in Q1 2026.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.